Highland Capital Management: Irving's Caris Life Sciences raises $310 million in growth capital

An Irving-based company has put together a massive financing deal as it takes on cancer. Caris Life Sciences said Tuesday it has raised $310 million in growth capital. That includes $235 million in equity financing and $75 million in debt, it said in a statement. "This financing represents the first significant external equity investment in Caris," Brian Brille, vice chairman of Caris, said in the statement. The company will use the funds to back its growth in precision medicine to improve...